Tags

Type your tag names separated by a space and hit enter

Electroencephalographic biofeedback (neurotherapy) as a treatment for attention deficit hyperactivity disorder: rationale and empirical foundation.

Abstract

During the past three decades, electroencephalographic (EEG) biofeedback has emerged as a nonpharmacologic treatment for attention-deficit/hyperactivity disorder (ADHD). This intervention was derived from operant conditioning studies that demonstrated capacity for neurophysiologic training in humans and other mammals and targets atypical patterns of cortical activation that have been identified consistently in neuroimaging and quantitative EEG studies of patients diagnosed with ADHD. This article presents the rationale for EEG biofeedback and examines the empirical support for this treatment using efficacy guidelines established by the Association for Applied Psychophysiology and Biofeedback and the International Society for Neuronal Regulation. Based on these guidelines, EEG biofeedback is considered to be "probably efficacious" for the treatment of ADHD and merits consideration as a treatment for patients who are stimulant "nonresponders." Although research findings published to date indicate positive clinical response in approximately 75% of patients treated in controlled group studies, additional randomized, controlled trials are needed to provide a better estimate of the robustness of this treatment.

Links

  • Publisher Full Text
  • Publisher Full Text
  • Authors+Show Affiliations

    FPI Attention Disorders Clinic, 2102 East Main Street, Endicott, NY 13760, USA. poppidoc@aol.com

    Source

    MeSH

    Adolescent
    Attention Deficit Disorder with Hyperactivity
    Biofeedback, Psychology
    Child
    Electroencephalography
    Humans

    Pub Type(s)

    Journal Article
    Review

    Language

    eng

    PubMed ID

    15564052

    Citation

    Monastra, Vincent J.. "Electroencephalographic Biofeedback (neurotherapy) as a Treatment for Attention Deficit Hyperactivity Disorder: Rationale and Empirical Foundation." Child and Adolescent Psychiatric Clinics of North America, vol. 14, no. 1, 2005, pp. 55-82, vi.
    Monastra VJ. Electroencephalographic biofeedback (neurotherapy) as a treatment for attention deficit hyperactivity disorder: rationale and empirical foundation. Child Adolesc Psychiatr Clin N Am. 2005;14(1):55-82, vi.
    Monastra, V. J. (2005). Electroencephalographic biofeedback (neurotherapy) as a treatment for attention deficit hyperactivity disorder: rationale and empirical foundation. Child and Adolescent Psychiatric Clinics of North America, 14(1), pp. 55-82, vi.
    Monastra VJ. Electroencephalographic Biofeedback (neurotherapy) as a Treatment for Attention Deficit Hyperactivity Disorder: Rationale and Empirical Foundation. Child Adolesc Psychiatr Clin N Am. 2005;14(1):55-82, vi. PubMed PMID: 15564052.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Electroencephalographic biofeedback (neurotherapy) as a treatment for attention deficit hyperactivity disorder: rationale and empirical foundation. A1 - Monastra,Vincent J, PY - 2004/11/27/pubmed PY - 2005/1/26/medline PY - 2004/11/27/entrez SP - 55-82, vi JF - Child and adolescent psychiatric clinics of North America JO - Child Adolesc Psychiatr Clin N Am VL - 14 IS - 1 N2 - During the past three decades, electroencephalographic (EEG) biofeedback has emerged as a nonpharmacologic treatment for attention-deficit/hyperactivity disorder (ADHD). This intervention was derived from operant conditioning studies that demonstrated capacity for neurophysiologic training in humans and other mammals and targets atypical patterns of cortical activation that have been identified consistently in neuroimaging and quantitative EEG studies of patients diagnosed with ADHD. This article presents the rationale for EEG biofeedback and examines the empirical support for this treatment using efficacy guidelines established by the Association for Applied Psychophysiology and Biofeedback and the International Society for Neuronal Regulation. Based on these guidelines, EEG biofeedback is considered to be "probably efficacious" for the treatment of ADHD and merits consideration as a treatment for patients who are stimulant "nonresponders." Although research findings published to date indicate positive clinical response in approximately 75% of patients treated in controlled group studies, additional randomized, controlled trials are needed to provide a better estimate of the robustness of this treatment. SN - 1056-4993 UR - https://www.unboundmedicine.com/medline/citation/15564052/full_citation L2 - https://linkinghub.elsevier.com/retrieve/pii/S1056-4993(04)00067-7 DB - PRIME DP - Unbound Medicine ER -